Geneva, Switzerland and Boston, MA - December 6, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the ...
Actualités similaires
Articles similaires à ObsEva SA - ObsEva SA to Participate in BMO Healthcare Conference December 12, 2018